Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 year

Stefan Esser*, Alexy Inciarte, Itzchak Levy, Antonella D.Arminio Monforte, John S. Lambert, Berend van Welzen, Katsuji Teruya, Marta Boffito, Chun Eng Liu, Ozlem A. Aydın, David Thorpe, Marion Heinzkill, Andrea Marongiu, Tali Cassidy, Richard Haubrich, Lisa D'Amato, Olivier Robineau

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 year'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science